About: Ioxaglic acid

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Ioxaglic acid (trade name Hexabrix) is pharmaceutical drug used as an iodinated contrast medium for X-ray imaging. It has low osmolality (relatively few molecules per volume), typically resulting in fewer side effects than high-osmolality media. It is manufactured by Guerbet, but marketing in the US has been discontinued. As of 2021, it may still be available in some European countries. It is applied in form of its salts, ioxaglate meglumine and ioxaglate sodium.

Property Value
dbo:abstract
  • Ioxaglic acid (trade name Hexabrix) is pharmaceutical drug used as an iodinated contrast medium for X-ray imaging. It has low osmolality (relatively few molecules per volume), typically resulting in fewer side effects than high-osmolality media. It is manufactured by Guerbet, but marketing in the US has been discontinued. As of 2021, it may still be available in some European countries. It is applied in form of its salts, ioxaglate meglumine and ioxaglate sodium. (en)
  • L’acido iossaglico è un mezzo di contrasto ionico, dimero, a bassa osmolalità, impiegato generalmente come sale di sodio (ioxaglato di sodio) e meglumina (ioxaglato di metilglucamina) per via endovenosa o per iniezione in distretti particolari durante procedure diagnostiche come angiografia, , urografia. (it)
dbo:alternativeName
  • Hexabrix (en)
dbo:casNumber
  • 59017-64-0
dbo:chEMBL
  • 1201291
dbo:drugbank
  • DB09313
dbo:fdaUniiCode
  • Z40X7EI2AF
dbo:kegg
  • D01761
dbo:pubchem
  • 3742
dbo:thumbnail
dbo:wikiPageID
  • 20362104 (xsd:integer)
dbo:wikiPageLength
  • 6669 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1016848550 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • V08 (en)
dbp:atcSuffix
  • AB03 (en)
dbp:c
  • 24 (xsd:integer)
dbp:casNumber
  • 59017 (xsd:integer)
dbp:chembl
  • 1201291 (xsd:integer)
dbp:chemspiderid
  • 3611 (xsd:integer)
dbp:drugbank
  • DB09313 (en)
dbp:eliminationHalfLife
  • 5520.0
dbp:excretion
  • Unchanged via kidneys (en)
dbp:h
  • 21 (xsd:integer)
dbp:i
  • 6 (xsd:integer)
dbp:iupacName
  • 3 (xsd:integer)
dbp:kegg
  • D01761 (en)
dbp:legalStatus
  • Rx-only (en)
dbp:metabolism
  • None (en)
dbp:n
  • 5 (xsd:integer)
dbp:o
  • 8 (xsd:integer)
dbp:proteinBound
  • 14.0
dbp:pubchem
  • 3742 (xsd:integer)
dbp:routesOfAdministration
dbp:smiles
  • CCNC1=CI (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • TYYBFXNZMFNZJT-UHFFFAOYSA-N (en)
dbp:tradename
  • Hexabrix (en)
dbp:unii
  • Z40X7EI2AF (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Ioxaglic acid (trade name Hexabrix) is pharmaceutical drug used as an iodinated contrast medium for X-ray imaging. It has low osmolality (relatively few molecules per volume), typically resulting in fewer side effects than high-osmolality media. It is manufactured by Guerbet, but marketing in the US has been discontinued. As of 2021, it may still be available in some European countries. It is applied in form of its salts, ioxaglate meglumine and ioxaglate sodium. (en)
  • L’acido iossaglico è un mezzo di contrasto ionico, dimero, a bassa osmolalità, impiegato generalmente come sale di sodio (ioxaglato di sodio) e meglumina (ioxaglato di metilglucamina) per via endovenosa o per iniezione in distretti particolari durante procedure diagnostiche come angiografia, , urografia. (it)
rdfs:label
  • Ioxaglic acid (en)
  • Acido iossaglico (it)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License